15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer


June 15 – 17, 2017
Emory Conference Center Hotel
Atlanta, Georgia


The 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer will focus on the exchange of innovative ideas among medical and pediatric oncologists (including fellows and residents), nurse practitioners, oncology nurses, and other associated allied health professionals. In the past, healthcare providers from Europe, Asia, Australia, South America, Canada and the United States have attended. This year’s symposium is designed to present the latest scientific and clinical advances regarding the science and ethics of genomic testing.

The speakers are leaders in their respective disciplines and will present up-to-the minute information that will make for a lively and productive meeting. We will also allocate two sessions for presentation of the best abstracts. For more information about the abstract submission process, please see the Preliminary Program.

  1. As a result of participating in this educational program, participants will be able to:

    • Describe the use of restriction enzymes for DNA sequencing
    • Discuss what a rare polymorphism is
    • Explain what infrastructure is necessary for GWAS
    • Describe when a genetic test is no longer a research test
    • Discuss the difference between research and clinical incidental findings
    • Explain the extent of institutional liability for violations of CLIA or federal regulations
    • Discuss the resources necessary to provide genetic counseling to survivors of childhood cancer
  2. The program will be of interest to pediatric hematologists/oncologists, pediatric nurse practitioners, pediatric psychologists, pediatric oncology nurses, pediatric oncology social workers, medical oncologists, family practice physicians, fellows, residents, interns, clinical research associates and other primary care providers, as well as scientists in non-clinical fields such as public health, the social sciences and laboratory sciences.

  3. St. Jude Children’s Research Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    St. Jude Children’s Research Hospital designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  4. A block of rooms has been reserved at the Emory Conference Center Hotel under the group name “St. Jude Children’s Research Hospital - 15th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer.”

    The conference rate is available until May 25, 2017 and is $180/night for single occupancy and $140/person/night for double occupancy.

    To make reservations:

    • Visit the reservation website (single occupancy only)
    • Call 800-933-6679 (single or double occupancy)

    For more information, please consult the Preliminary Program.

  5. Registration Fees

    All fees in U.S. currency.

      Early Registration (until April 1, 2017) Regular Registration (after April 1, 2017)
    Physician $450 $500
    Nonphysician (PhD, NP, PA, Nurse, Fellow) $425 $450
    Students and other healthcare professionals $350 $350

    In addition, meal passes are available for a spouse or other guest:

    Guest for dinner Friday night (6/16/2017): $80

    Guest for all conference meals: $350*

    *Does not authorize access to scientific sessions

    Refund Policy

    Registration cancellations or substitutions must be received by mail, fax or email by May 14, 2017. No registration refunds will be granted after that date; however, you may transfer your registration to a colleague. An administration fee of $50.00 will be assessed for cancellations received anytime.

  6. April 1, 2017: Early registration ends.

    May 25, 2017: Deadline to reserve rooms in dedicated hotel block.

    February 4, 2017: Abstract submission deadline. For more information regarding abstract submission, see the Preliminary Program.

  7. Smita Bhatia, MD, MPH
    City of Hope, Duarte, CA

    Jacqueline Casillas, MD, MSHS
    UCLA Medical Center, Los Angeles, CA

    Giulio D’Angio, MD
    University of Pennsylvania, Philadelphia, PA

    Lisa Diller, MD
    Dana-Farber Cancer Institute, Boston, MA

    Luther Gene Folson
    Water Valley, MS

    Melissa Hudson, MD
    St. Jude Children’s Research Hospital, Memphis, TN

    Grace Powers Monaco, JD
    Medical Care Ombudsman Program, Montross, VA

    Kevin Oeffinger, MD
    Memorial Sloan Kettering Cancer Center, New York, NY

    David Poplack, MD
    Texas Children’s Cancer Center at Baylor College of Medicine, Houston, TX

    Leslie Robison, PhD
    St. Jude Children’s Research Hospital, Memphis, TN

    Charles Sklar, MD
    Memorial Sloan Kettering Cancer Center, New York, NY

    Flora van Leeuwen, PhD
    Netherlands Cancer Institute, Amsterdam, The Netherlands

    Jeanette Falck Winther, MD
    Danish Cancer Society Research Center, Copenhagen, Denmark


Conference Agenda 
Thursday, June 15
2:00 - 9:00 p.m. Registration
3:00 p.m. Welcome: Daniel M. Green, MD, Conference Chairman
3:00 – 6:15 p.m. Session I: Invited Speakers — Moderator: Lisa Diller, MD
3:00 p.m. Overview of DNA Structure and Biology of Genetic Testing
Sharon E. Plon, MD, PhD, Baylor College of Medicine, Houston, Texas
3:45 p.m.  The Clinical Implications of Rare Polymorphisms
Lindsay M. Morton, PhD, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
4:30 p.m. The Strengths, Limitations and Challenges Associated with Genetic Testing: from Genome-wide Association to Genetic Sequencing
Smita Bhatia, MD, MPH, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama
5:15 p.m. When Is a Genetic Result Ready for Prime Time?
Stephen J. Chanock, MD, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland
6:00 p.m.  Discussion
6:15 p.m. Adjourn
7:00 – 9:00 p.m. Welcome reception
Friday, June 16
7:00 a.m. Registration
7:00 – 8:00 a.m. Continental breakfast
8:00 a.m. – 12:00 p.m. Session II: Platform presentations — Moderator: Smita Bhatia, MD, MPH
10:00 a.m. Refreshment break
12:00 p.m. Lunch
1:30 – 5:00 p.m. Session III: Platform presentations — Moderator: Jacqueline Casillas, MD, MSHS
3:00 p.m. Refreshment break
5:00 p.m. Adjourn
6:30 p.m. Reception
7:00 – 10:30 p.m. Group dinner
7:30 – 10:00 p.m. Poster viewing
Saturday, June 17  
7:30 a.m. Registration
7:30 – 8:30 a.m. Continental breakfast
8:30 a.m. – 12:00 p.m. Session IV: Invited Speakers — Moderator: Flora Van Leeuwen, PhD
8:30 a.m. The Ethics of Return of Results: Addressing Incidental Findings in Pediatric Cancer Survivors
Angela R. Bradbury, MD, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
9:30 a.m.  Return of Results: The Intersection of HIPAA, CLIA, Federal Regulations, and Institutional Liability
Ellen Wright Clayton, MD, JD, Center for Genetic and Health Policy, Vanderbilt University, Nashville, Tennessee
10:30 a.m. Considerations for Genetic Counseling of Adults Survivors of Childhood Cancer
Kim Nichols, MD, Cancer Predisposition Program, St. Jude Children’s Research Hospital, Memphis, Tennessee
11:30 a.m. Discussion

12:00 p.m.


Register for this Conference